Top News Stories

In April 2025, Harvard University initiated a legal challenge against the Trump administration, contesting the federal government's decision to freeze $2.2 billion in grants. This action was perceived by Harvard as an attempt to exert control over the university's academic decisions, particularly in response to campus protests concerning the Gaza conflict. The administration's demands included the appointment of an external overseer to ensure "viewpoint diversity," which Harvard viewed as a direct infringement on its academic freedom.

On April 22, 2025, U.S. Secretary of State Marco Rubio unveiled a sweeping reorganization of the Department of State, marking one of the most significant restructurings in the department's history. This initiative, aligned with President Donald Trump's "America First" doctrine, aims to streamline diplomatic operations, reduce overseas missions, and integrate offices previously focused on promoting liberal values into broader regional bureaus. Rubio characterized the existing structure as a "sprawling bureaucracy" more aligned with "radical political ideology" than with advancing America's core national interests.

The recent appearance of former U.S. President Donald Trump alongside conservative commentator Pete Hegseth at a political gathering that sharply criticized American universities marks a new crescendo in the nation's long-standing culture war over education. Held at Florida's Signal conference, the event was emblematic of a larger political and ideological confrontation that has defined recent years: the conservative campaign against perceived liberal bias, identity politics, and "wokeism" in academia.

The soaring cost of prescription drugs in the United States has long stirred public discontent and bipartisan concern. In April 2025, former President Donald J. Trump, now a leading candidate in the upcoming election cycle, signaled a renewed focus on this issue. According to a Reuters report (April 22, 2025), Trump is considering reintroducing international reference pricing (IRP) as a cost-control measure for U.S. drug prices. This policy, widely discussed during his first term and later blocked by federal courts, would benchmark U.S. drug prices against those paid in other wealthy nations like Sweden, Japan, and Canada.

On April 22, 2025, the International Monetary Fund (IMF) issued a grim warning that sent ripples through financial markets and global policymaking communities: the sweeping tariff increases initiated by former U.S. President Donald Trump had unleashed what it termed a "major negative shock" to the global economy. This dramatic development, paired with downgraded growth forecasts for nearly every major economy—including the United States, United Kingdom, and numerous developing countries—ushers in a critical juncture in trade policy, international economic law, and global governance.

In a digital age dominated by short-form video content, TikTok has emerged as one of the most culturally influential apps in the world—especially in...